Retrospective Study in Patients Receiving Two or More OZURDEX® Injections for Retinal Vein Occlusion (RVO)

NCT01411696 · clinicaltrials.gov ↗

COMPLETED

Status

289

Enrollment

INDUSTRY

Sponsor class

Conditions

Retinal Vein Occlusion
Macular Edema

Interventions

DRUG: dexamethasone intravitreal implant 0.7 mg

Sponsor

Allergan